Christine Chung

Trials

Studies that name Christine Chung as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:48 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT06855212 · Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC

  H. Lee Moffitt Cancer Center and Research Institute · active not recruiting · Head and Neck Squamous Cell Carcinoma · principal investigator
• Ph2
  NCT06597565 · A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

  H. Lee Moffitt Cancer Center and Research Institute · recruiting · Head and Neck Squamous Cell Carcinoma · principal investigator
• N/A
  NCT05083416 · Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome

  H. Lee Moffitt Cancer Center and Research Institute · completed · Head and Neck Cancer · principal investigator
• Ph1
  NCT03381183 · IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma

  H. Lee Moffitt Cancer Center and Research Institute · completed · Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck, Metastatic Squamous Cell Carcinoma · principal investigator
• Ph2
  NCT02218164 · Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma

  H. Lee Moffitt Cancer Center and Research Institute · completed · Squamous Cell Carcinoma of Skin, Carcinoma, Squamous Cell · principal investigator
• Ph2
  NCT01824823 · Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence

  ECOG-ACRIN Cancer Research Group · terminated · Head and Neck Squamous Cell Carcinoma · principal investigator
• Ph1/Ph2
  NCT01732640 · A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC.

  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · terminated · Squamous Cell Carcinoma of the Head and Neck · principal investigator
• N/A
  NCT01124669 · Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib Tosylate

  ECOG-ACRIN Cancer Research Group · completed · Lung Cancer · principal investigator
• N/A
  NCT00898911 · Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer

  ECOG-ACRIN Cancer Research Group · completed · Head and Neck Cancer · study chair
• Ph1
  NCT00350233 · MR Guided Focused Ultrasound Surgery of Metastatic Bone Tumors

  InSightec · completed · Bone Metastases · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• MR Biomarkers of Inflammation in Knee Osteoarthritis
  I01CX000625 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · fiscal years 2012 to 2026
  Same name and institution; not confirmed by an ID
• Ultrasensitive detection of circulating DNA methylation for head and neck cancer prognosis
  R01DE034377 · NIDCR · H. LEE MOFFITT CANCER CTR & RES INST · fiscal years 2025 to 2026 · $712,674 awarded in 2026
  Same name and institution; not confirmed by an ID
• Joint Imaging Core of the MARC
  P30AR073761 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2018 to 2022 · $163,192 awarded in 2022
  Same name and institution; not confirmed by an ID
• UTE MRI of Tissue Response in Meniscal Repair
  R01AR064321 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2014 to 2018 · $469,645 awarded in 2018
  Same name and institution; not confirmed by an ID
• Development and Translation of Novel UTE-MuSIC MR Sequence to Image Around Metal
  I01RX001265 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · fiscal years 2014 to 2017
  Same name and institution; not confirmed by an ID
• Chung R21 Transfer From JHU
  R21DE023430 · NIDCR · H. LEE MOFFITT CANCER CTR & RES INST · fiscal years 2014 to 2015 · $168,023 awarded in 2015
  Same name and institution; not confirmed by an ID
• Novel 3T MRI of TMJ Using Short and Ultrashort Echo Time (UTE) Techniques
  R01DE022068 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2011 to 2014 · $558,980 awarded in 2014
  Same name and institution; not confirmed by an ID
• Molecular signatures of HNSCC in response to targeted therapies
  R01DE017982 · NIDCR · JOHNS HOPKINS UNIVERSITY · fiscal years 2007 to 2011 · $389,392 awarded in 2011
  Same name and institution; not confirmed by an ID
• 3T MRI OF THE TMJ USING SHORT AND ULTRASHORT ECHO TIME (UTE) TECHNIQUES
  R21DE019008 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2008 to 2009 · $193,125 awarded in 2009
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Eastern Cooperative Oncology Group Operations Office
  U10CA021115 · NCI · FRONTIER SCI & TECHNOLOGY RSCH FDN, INC · PI ROBERT L COMIS · fiscal years 1985 to 2013
  Named on NCT01824823